ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count	ensembl_gene_id	gene_symbol
R-HSA-156588	Glucuronidation	5/167	14/7349	9.67964132386586e-06	0.00485917994458066	0.00485917994458066	54578/7364/7366/10720/54658	5	ENSG00000167165,ENSG00000171234,ENSG00000196620,ENSG00000213759,ENSG00000241635	UGT1A6,UGT2B7,UGT2B15,UGT2B11,UGT1A1
R-HSA-2142753	Arachidonic acid metabolism	6/167	42/7349	0.000335064252089121	0.061156693854881	0.061156693854881	22949/2166/2053/145482/1557/57834	6	ENSG00000106853,ENSG00000117480,ENSG00000120915,ENSG00000140043,ENSG00000165841,ENSG00000171903	PTGR1,FAAH,EPHX2,PTGR2,CYP2C19,CYP4F11
R-HSA-8978868	Fatty acid metabolism	11/167	142/7349	0.000365478250128771	0.061156693854881	0.061156693854881	2182/22949/6342/2166/2053/3032/145482/283927/1376/1557/57834	11	ENSG00000068366,ENSG00000106853,ENSG00000116171,ENSG00000117480,ENSG00000120915,ENSG00000138029,ENSG00000140043,ENSG00000140876,ENSG00000157184,ENSG00000165841,ENSG00000171903	ACSL4,PTGR1,SCP2,FAAH,EPHX2,HADHB,PTGR2,NUDT7,CPT2,CYP2C19,CYP4F11
R-HSA-211859	Biological oxidations	10/167	141/7349	0.00133786029770578	0.167901467362076	0.167901467362076	26/196/7172/1557/54578/7364/57834/7366/10720/54658	10	ENSG00000002726,ENSG00000106546,ENSG00000137364,ENSG00000165841,ENSG00000167165,ENSG00000171234,ENSG00000171903,ENSG00000196620,ENSG00000213759,ENSG00000241635	AOC1,AHR,TPMT,CYP2C19,UGT1A6,UGT2B7,CYP4F11,UGT2B15,UGT2B11,UGT1A1
R-HSA-156580	Phase II - Conjugation of compounds	6/167	66/7349	0.00370667891046388	0.328025710507179	0.328025710507179	7172/54578/7364/7366/10720/54658	6	ENSG00000137364,ENSG00000167165,ENSG00000171234,ENSG00000196620,ENSG00000213759,ENSG00000241635	TPMT,UGT1A6,UGT2B7,UGT2B15,UGT2B11,UGT1A1
R-HSA-112310	Neurotransmitter release cycle	4/167	29/7349	0.00392062602199816	0.328025710507179	0.328025710507179	7915/2744/8573/18	4	ENSG00000112294,ENSG00000115419,ENSG00000147044,ENSG00000183044	ALDH5A1,GLS,CASK,ABAT
R-HSA-9033241	Peroxisomal protein import	5/167	57/7349	0.00921834686430299	0.580327330336829	0.580327330336829	6342/2053/3417/283927/8528	5	ENSG00000116171,ENSG00000120915,ENSG00000138413,ENSG00000140876,ENSG00000203797	SCP2,EPHX2,IDH1,NUDT7,DDO
R-HSA-5619115	Disorders of transmembrane transporters	7/167	105/7349	0.00973507811990599	0.580327330336829	0.580327330336829	11136/1244/368/6523/23443/6519/11160	7	ENSG00000021488,ENSG00000023839,ENSG00000091262,ENSG00000100170,ENSG00000117620,ENSG00000138079,ENSG00000147475	SLC7A9,ABCC2,ABCC6,SLC5A1,SLC35A3,SLC3A1,ERLIN2
R-HSA-5619102	SLC transporter disorders	4/167	38/7349	0.0104042748466762	0.580327330336829	0.580327330336829	11136/6523/23443/6519	4	ENSG00000021488,ENSG00000100170,ENSG00000117620,ENSG00000138079	SLC7A9,SLC5A1,SLC35A3,SLC3A1
R-HSA-425407	SLC-mediated transmembrane transport	8/167	153/7349	0.02301436213531	0.877066687177192	0.877066687177192	11136/6523/23516/23443/1317/6519/23382/91749	8	ENSG00000021488,ENSG00000100170,ENSG00000104635,ENSG00000117620,ENSG00000136868,ENSG00000138079,ENSG00000158467,ENSG00000173214	SLC7A9,SLC5A1,SLC39A14,SLC35A3,SLC31A1,SLC3A1,AHCYL2,KIAA1919
R-HSA-888590	GABA synthesis, release, reuptake and degradation	2/167	11/7349	0.0246750287344672	0.877066687177192	0.877066687177192	7915/18	2	ENSG00000112294,ENSG00000183044	ALDH5A1,ABAT
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	2/167	12/7349	0.0291739904097753	0.877066687177192	0.877066687177192	22949/57834	2	ENSG00000106853,ENSG00000171903	PTGR1,CYP4F11
R-HSA-5668914	Diseases of metabolism	5/167	78/7349	0.0318622793351608	0.877066687177192	0.877066687177192	29080/2799/7172/3417/54658	5	ENSG00000133773,ENSG00000135677,ENSG00000137364,ENSG00000138413,ENSG00000241635	CCDC59,GNS,TPMT,IDH1,UGT1A1
R-HSA-418885	DCC mediated attractive signaling	2/167	13/7349	0.0339715747286536	0.877066687177192	0.877066687177192	3983/4690	2	ENSG00000099204,ENSG00000158092	ABLIM1,NCK1
R-HSA-8963743	Digestion and absorption	2/167	13/7349	0.0339715747286536	0.877066687177192	0.877066687177192	6523/8972	2	ENSG00000100170,ENSG00000257335	SLC5A1,MGAM
R-HSA-9018678	Biosynthesis of specialized proresolving mediators (SPMs)	2/167	13/7349	0.0339715747286536	0.877066687177192	0.877066687177192	22949/2053	2	ENSG00000106853,ENSG00000120915	PTGR1,EPHX2
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	3/167	32/7349	0.0353046211987618	0.877066687177192	0.877066687177192	118788/4690/4067	3	ENSG00000155629,ENSG00000158092,ENSG00000254087	PIK3AP1,NCK1,LYN
R-HSA-211981	Xenobiotics	2/167	14/7349	0.0390520591315842	0.877066687177192	0.877066687177192	196/1557	2	ENSG00000106546,ENSG00000165841	AHR,CYP2C19
R-HSA-937039	IRAK1 recruits IKK complex	2/167	14/7349	0.0390520591315842	0.877066687177192	0.877066687177192	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	2/167	14/7349	0.0390520591315842	0.877066687177192	0.877066687177192	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-202733	Cell surface interactions at the vascular wall	5/167	83/7349	0.0400820171361554	0.877066687177192	0.877066687177192	11136/4680/2734/4312/4067	5	ENSG00000021488,ENSG00000086548,ENSG00000090863,ENSG00000196611,ENSG00000254087	SLC7A9,CEACAM6,GLG1,MMP1,LYN
R-HSA-1630316	Glycosaminoglycan metabolism	5/167	84/7349	0.0418669085307518	0.877066687177192	0.877066687177192	9957/3074/2799/92126/10855	5	ENSG00000002587,ENSG00000049860,ENSG00000135677,ENSG00000171451,ENSG00000173083	HS3ST1,HEXB,GNS,DSEL,HPSE
R-HSA-189200	Cellular hexose transport	2/167	15/7349	0.0444002739537349	0.877066687177192	0.877066687177192	6523/91749	2	ENSG00000100170,ENSG00000173214	SLC5A1,KIAA1919
R-HSA-5621480	Dectin-2 family	2/167	15/7349	0.0444002739537349	0.877066687177192	0.877066687177192	4588/4067	2	ENSG00000184956,ENSG00000254087	MUC6,LYN
R-HSA-382551	Transport of small molecules	17/167	484/7349	0.0477396068722172	0.877066687177192	0.877066687177192	11136/1244/368/6523/23516/3988/1181/23443/9429/8165/1317/6519/4547/11160/818/23382/91749	17	ENSG00000021488,ENSG00000023839,ENSG00000091262,ENSG00000100170,ENSG00000104635,ENSG00000107798,ENSG00000114859,ENSG00000117620,ENSG00000118777,ENSG00000121057,ENSG00000136868,ENSG00000138079,ENSG00000138823,ENSG00000147475,ENSG00000148660,ENSG00000158467,ENSG00000173214	SLC7A9,ABCC2,ABCC6,SLC5A1,SLC39A14,LIPA,CLCN2,SLC35A3,ABCG2,AKAP1,SLC31A1,SLC3A1,MTTP,ERLIN2,CAMK2G,AHCYL2,KIAA1919
R-HSA-211897	Cytochrome P450 - arranged by substrate type	3/167	37/7349	0.0509759533598256	0.877066687177192	0.877066687177192	196/1557/57834	3	ENSG00000106546,ENSG00000165841,ENSG00000171903	AHR,CYP2C19,CYP4F11
R-HSA-450294	MAP kinase activation	4/167	63/7349	0.054459811187	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-373753	Nephrin family interactions	2/167	17/7349	0.0558418805578673	0.877066687177192	0.877066687177192	8573/4690	2	ENSG00000147044,ENSG00000158092	CASK,NCK1
R-HSA-73780	RNA Polymerase III Chain Elongation	2/167	18/7349	0.0619075489454679	0.877066687177192	0.877066687177192	55703/10621	2	ENSG00000013503,ENSG00000132664	POLR3B,POLR3F
R-HSA-448424	Interleukin-17 signaling	4/167	67/7349	0.06544389130642	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment 	2/167	19/7349	0.0681854697329364	0.877066687177192	0.877066687177192	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-1483249	Inositol phosphate metabolism	3/167	42/7349	0.0694544775719041	0.877066687177192	0.877066687177192	51196/9677/55190	3	ENSG00000138193,ENSG00000168781,ENSG00000196368	PLCE1,PPIP5K1,NUDT11
R-HSA-199992	trans-Golgi Network Vesicle Budding	4/167	69/7349	0.0713380622306123	0.877066687177192	0.877066687177192	6845/2799/10618/6643	4	ENSG00000124333,ENSG00000135677,ENSG00000152291,ENSG00000205302	VAMP7,GNS,TGOLN2,SNX2
R-HSA-421837	Clathrin derived vesicle budding	4/167	69/7349	0.0713380622306123	0.877066687177192	0.877066687177192	6845/2799/10618/6643	4	ENSG00000124333,ENSG00000135677,ENSG00000152291,ENSG00000205302	VAMP7,GNS,TGOLN2,SNX2
R-HSA-211945	Phase I - Functionalization of compounds	4/167	70/7349	0.0743839738333908	0.877066687177192	0.877066687177192	26/196/1557/57834	4	ENSG00000002726,ENSG00000106546,ENSG00000165841,ENSG00000171903	AOC1,AHR,CYP2C19,CYP4F11
R-HSA-210991	Basigin interactions	2/167	20/7349	0.0746629954749557	0.877066687177192	0.877066687177192	11136/4312	2	ENSG00000021488,ENSG00000196611	SLC7A9,MMP1
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	2/167	21/7349	0.0813279378331185	0.877066687177192	0.877066687177192	7172/54658	2	ENSG00000137364,ENSG00000241635	TPMT,UGT1A1
R-HSA-425410	Metal ion SLC transporters	2/167	22/7349	0.0881685534468051	0.877066687177192	0.877066687177192	23516/1317	2	ENSG00000104635,ENSG00000136868	SLC39A14,SLC31A1
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	2/167	22/7349	0.0881685534468051	0.877066687177192	0.877066687177192	5601/387522	2	ENSG00000050748,ENSG00000124208	MAPK9,TMEM189-UBE2V1
R-HSA-70895	Branched-chain amino acid catabolism	2/167	22/7349	0.0881685534468051	0.877066687177192	0.877066687177192	11112/26275	2	ENSG00000106049,ENSG00000198130	HIBADH,HIBCH
R-HSA-73980	RNA Polymerase III Transcription Termination	2/167	23/7349	0.0951735302030617	0.877066687177192	0.877066687177192	55703/10621	2	ENSG00000013503,ENSG00000132664	POLR3B,POLR3F
R-HSA-937041	IKK complex recruitment mediated by RIP1	2/167	23/7349	0.0951735302030617	0.877066687177192	0.877066687177192	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	5/167	108/7349	0.0989673667989217	0.877066687177192	0.877066687177192	4775/118788/4690/1147/4067	5	ENSG00000072736,ENSG00000155629,ENSG00000158092,ENSG00000213341,ENSG00000254087	NFATC3,PIK3AP1,NCK1,CHUK,LYN
R-HSA-352230	Amino acid transport across the plasma membrane	2/167	24/7349	0.102331973894805	0.877066687177192	0.877066687177192	11136/6519	2	ENSG00000021488,ENSG00000138079	SLC7A9,SLC3A1
R-HSA-389661	Glyoxylate metabolism and glycine degradation	2/167	24/7349	0.102331973894805	0.877066687177192	0.877066687177192	55526/8528	2	ENSG00000181192,ENSG00000203797	DHTKD1,DDO
R-HSA-4085001	Sialic acid metabolism	2/167	24/7349	0.102331973894805	0.877066687177192	0.877066687177192	8869/10020	2	ENSG00000115525,ENSG00000159921	ST3GAL5,GNE
R-HSA-112315	Transmission across Chemical Synapses	5/167	110/7349	0.104930011156384	0.877066687177192	0.877066687177192	7915/2744/8573/818/18	5	ENSG00000112294,ENSG00000115419,ENSG00000147044,ENSG00000148660,ENSG00000183044	ALDH5A1,GLS,CASK,CAMK2G,ABAT
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	4/167	80/7349	0.108310776188172	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	4/167	80/7349	0.108310776188172	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-975871	MyD88 cascade initiated on plasma membrane	4/167	80/7349	0.108310776188172	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-1638074	Keratan sulfate/keratin metabolism	2/167	25/7349	0.109633395256961	0.877066687177192	0.877066687177192	3074/2799	2	ENSG00000049860,ENSG00000135677	HEXB,GNS
R-HSA-2871809	FCERI mediated Ca+2 mobilization	2/167	25/7349	0.109633395256961	0.877066687177192	0.877066687177192	4775/4067	2	ENSG00000072736,ENSG00000254087	NFATC3,LYN
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	2/167	25/7349	0.109633395256961	0.877066687177192	0.877066687177192	2744/256987	2	ENSG00000115419,ENSG00000164300	GLS,SERINC5
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	3/167	52/7349	0.113882035302441	0.877066687177192	0.877066687177192	8869/116150/10020	3	ENSG00000115525,ENSG00000153989,ENSG00000159921	ST3GAL5,NUS1,GNE
R-HSA-2871796	FCERI mediated MAPK activation	2/167	26/7349	0.117067697370401	0.877066687177192	0.877066687177192	5601/4067	2	ENSG00000050748,ENSG00000254087	MAPK9,LYN
R-HSA-390918	Peroxisomal lipid metabolism	2/167	26/7349	0.117067697370401	0.877066687177192	0.877066687177192	6342/283927	2	ENSG00000116171,ENSG00000140876	SCP2,NUDT7
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	2/167	26/7349	0.117067697370401	0.877066687177192	0.877066687177192	79728/4683	2	ENSG00000083093,ENSG00000104320	PALB2,NBN
R-HSA-6798695	Neutrophil degranulation	12/167	361/7349	0.119143386023137	0.877066687177192	0.877066687177192	26/3074/4680/25801/25797/84418/2799/3417/10788/10855/387263/8972	12	ENSG00000002726,ENSG00000049860,ENSG00000086548,ENSG00000115271,ENSG00000115828,ENSG00000120306,ENSG00000135677,ENSG00000138413,ENSG00000145703,ENSG00000173083,ENSG00000185127,ENSG00000257335	AOC1,HEXB,CEACAM6,GCA,QPCT,CYSTM1,GNS,IDH1,IQGAP2,HPSE,C6orf120,MGAM
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	2/167	27/7349	0.12462516342381	0.877066687177192	0.877066687177192	55703/10621	2	ENSG00000013503,ENSG00000132664	POLR3B,POLR3F
R-HSA-1500931	Cell-Cell communication	4/167	85/7349	0.127478077968185	0.877066687177192	0.877066687177192	64398/1015/8573/4690	4	ENSG00000072415,ENSG00000079112,ENSG00000147044,ENSG00000158092	MPP5,CDH17,CASK,NCK1
R-HSA-432722	Golgi Associated Vesicle Biogenesis	3/167	55/7349	0.128888874639974	0.877066687177192	0.877066687177192	6845/10618/6643	3	ENSG00000124333,ENSG00000152291,ENSG00000205302	VAMP7,TGOLN2,SNX2
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	4/167	86/7349	0.131473145061708	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-499943	Interconversion of nucleotide di- and triphosphates	2/167	28/7349	0.132296444823884	0.877066687177192	0.877066687177192	50484/122481	2	ENSG00000048392,ENSG00000140057	RRM2B,AK7
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	2/167	28/7349	0.132296444823884	0.877066687177192	0.877066687177192	55703/10621	2	ENSG00000013503,ENSG00000132664	POLR3B,POLR3F
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	2/167	28/7349	0.132296444823884	0.877066687177192	0.877066687177192	55703/10621	2	ENSG00000013503,ENSG00000132664	POLR3B,POLR3F
R-HSA-8949613	Cristae formation	2/167	28/7349	0.132296444823884	0.877066687177192	0.877066687177192	3313/139322	2	ENSG00000113013,ENSG00000155008	HSPA9,APOOL
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	5/167	120/7349	0.137284646002191	0.877066687177192	0.877066687177192	5601/4775/387522/1147/4067	5	ENSG00000050748,ENSG00000072736,ENSG00000124208,ENSG00000213341,ENSG00000254087	MAPK9,NFATC3,TMEM189-UBE2V1,CHUK,LYN
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	4/167	88/7349	0.139616727910944	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	4/167	88/7349	0.139616727910944	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	4/167	88/7349	0.139616727910944	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-975155	MyD88 dependent cascade initiated on endosome	4/167	88/7349	0.139616727910944	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-1592230	Mitochondrial biogenesis	4/167	89/7349	0.143763125502417	0.877066687177192	0.877066687177192	4208/3313/139322/133522	4	ENSG00000081189,ENSG00000113013,ENSG00000155008,ENSG00000155846	MEF2C,HSPA9,APOOL,PPARGC1B
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	4/167	89/7349	0.143763125502417	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	4/167	89/7349	0.143763125502417	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-5621481	C-type lectin receptors (CLRs)	5/167	122/7349	0.144236058620994	0.877066687177192	0.877066687177192	4775/387522/4588/1147/4067	5	ENSG00000072736,ENSG00000124208,ENSG00000184956,ENSG00000213341,ENSG00000254087	NFATC3,TMEM189-UBE2V1,MUC6,CHUK,LYN
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	2/167	31/7349	0.15590497817307	0.877066687177192	0.877066687177192	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	2/167	31/7349	0.15590497817307	0.877066687177192	0.877066687177192	5601/4208	2	ENSG00000050748,ENSG00000081189	MAPK9,MEF2C
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	4/167	92/7349	0.156487727808721	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	2/167	32/7349	0.163945001971357	0.877066687177192	0.877066687177192	3074/92126	2	ENSG00000049860,ENSG00000171451	HEXB,DSEL
R-HSA-373752	Netrin-1 signaling	2/167	32/7349	0.163945001971357	0.877066687177192	0.877066687177192	3983/4690	2	ENSG00000099204,ENSG00000158092	ABLIM1,NCK1
R-HSA-432720	Lysosome Vesicle Biogenesis	2/167	32/7349	0.163945001971357	0.877066687177192	0.877066687177192	6845/2799	2	ENSG00000124333,ENSG00000135677	VAMP7,GNS
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	2/167	32/7349	0.163945001971357	0.877066687177192	0.877066687177192	79728/4683	2	ENSG00000083093,ENSG00000104320	PALB2,NBN
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	2/167	33/7349	0.172057228498937	0.877066687177192	0.877066687177192	9957/10855	2	ENSG00000002587,ENSG00000173083	HS3ST1,HPSE
R-HSA-5693537	Resolution of D-Loop Structures	2/167	33/7349	0.172057228498937	0.877066687177192	0.877066687177192	79728/4683	2	ENSG00000083093,ENSG00000104320	PALB2,NBN
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	4/167	96/7349	0.174078202260805	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	3/167	64/7349	0.17759141871951	0.877066687177192	0.877066687177192	55703/10621/1147	3	ENSG00000013503,ENSG00000132664,ENSG00000213341	POLR3B,POLR3F,CHUK
R-HSA-877300	Interferon gamma signaling	3/167	64/7349	0.17759141871951	0.877066687177192	0.877066687177192	3459/23321/818	3	ENSG00000027697,ENSG00000109654,ENSG00000148660	IFNGR1,TRIM2,CAMK2G
R-HSA-166166	MyD88-independent TLR4 cascade 	4/167	97/7349	0.178579733197925	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling 	4/167	97/7349	0.178579733197925	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-168638	NOD1/2 Signaling Pathway	2/167	35/7349	0.188469101265439	0.877066687177192	0.877066687177192	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	3/167	67/7349	0.194830959264467	0.877066687177192	0.877066687177192	8869/116150/10020	3	ENSG00000115525,ENSG00000153989,ENSG00000159921	ST3GAL5,NUS1,GNE
R-HSA-5619084	ABC transporter disorders	3/167	67/7349	0.194830959264467	0.877066687177192	0.877066687177192	1244/368/11160	3	ENSG00000023839,ENSG00000091262,ENSG00000147475	ABCC2,ABCC6,ERLIN2
R-HSA-6802957	Oncogenic MAPK signaling	3/167	67/7349	0.194830959264467	0.877066687177192	0.877066687177192	153090/55109/161742	3	ENSG00000136848,ENSG00000164252,ENSG00000166068	DAB2IP,AGGF1,SPRED1
R-HSA-76046	RNA Polymerase III Transcription Initiation	2/167	36/7349	0.196754878808548	0.877066687177192	0.877066687177192	55703/10621	2	ENSG00000013503,ENSG00000132664	POLR3B,POLR3F
R-HSA-9020591	Interleukin-12 signaling	2/167	36/7349	0.196754878808548	0.877066687177192	0.877066687177192	3313/6845	2	ENSG00000113013,ENSG00000124333	HSPA9,VAMP7
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	3/167	68/7349	0.200668179489629	0.877066687177192	0.877066687177192	11136/6519/23382	3	ENSG00000021488,ENSG00000138079,ENSG00000158467	SLC7A9,SLC3A1,AHCYL2
R-HSA-421270	Cell-cell junction organization	2/167	37/7349	0.205085103119903	0.877066687177192	0.877066687177192	64398/1015	2	ENSG00000072415,ENSG00000079112	MPP5,CDH17
R-HSA-1483115	Hydrolysis of LPC	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	79887	1	ENSG00000121316	PLBD1
R-HSA-1483213	Synthesis of PE	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	85465	1	ENSG00000138018	EPT1
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	6342	1	ENSG00000116171	SCP2
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	6342	1	ENSG00000116171	SCP2
R-HSA-210745	Regulation of gene expression in beta cells	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	3174	1	ENSG00000164749	HNF4G
R-HSA-210990	PECAM1 interactions	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-2160916	Hyaluronan uptake and degradation	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	3074	1	ENSG00000049860	HEXB
R-HSA-381753	Olfactory Signaling Pathway	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	64108	1	ENSG00000136514	RTP4
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	1803	1	ENSG00000197635	DPP4
R-HSA-450341	Activation of the AP-1 family of transcription factors	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	5601	1	ENSG00000050748	MAPK9
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	1/167	10/7349	0.20547119945413	0.877066687177192	0.877066687177192	4683	1	ENSG00000104320	NBN
R-HSA-71291	Metabolism of amino acids and derivatives	9/167	292/7349	0.219324091950302	0.877066687177192	0.877066687177192	11112/2744/262/445/256987/55526/26275/8528/1159	9	ENSG00000106049,ENSG00000115419,ENSG00000123505,ENSG00000130707,ENSG00000164300,ENSG00000181192,ENSG00000198130,ENSG00000203797,ENSG00000237289	HIBADH,GLS,AMD1,ASS1,SERINC5,DHTKD1,HIBCH,DDO,CKMT1B
R-HSA-156581	Methylation	1/167	11/7349	0.223550816526096	0.877066687177192	0.877066687177192	7172	1	ENSG00000137364	TPMT
R-HSA-2025928	Calcineurin activates NFAT	1/167	11/7349	0.223550816526096	0.877066687177192	0.877066687177192	4775	1	ENSG00000072736	NFATC3
R-HSA-2206281	Mucopolysaccharidoses	1/167	11/7349	0.223550816526096	0.877066687177192	0.877066687177192	2799	1	ENSG00000135677	GNS
R-HSA-400508	Incretin synthesis, secretion, and inactivation	1/167	11/7349	0.223550816526096	0.877066687177192	0.877066687177192	1803	1	ENSG00000197635	DPP4
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	1/167	11/7349	0.223550816526096	0.877066687177192	0.877066687177192	818	1	ENSG00000148660	CAMK2G
R-HSA-5625970	RHO GTPases activate KTN1	1/167	11/7349	0.223550816526096	0.877066687177192	0.877066687177192	3799	1	ENSG00000170759	KIF5B
R-HSA-2871837	FCERI mediated NF-kB activation	3/167	73/7349	0.23042952064302	0.877066687177192	0.877066687177192	387522/1147/4067	3	ENSG00000124208,ENSG00000213341,ENSG00000254087	TMEM189-UBE2V1,CHUK,LYN
R-HSA-74158	RNA Polymerase III Transcription	2/167	41/7349	0.238729284278548	0.877066687177192	0.877066687177192	55703/10621	2	ENSG00000013503,ENSG00000132664	POLR3B,POLR3F
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	2/167	41/7349	0.238729284278548	0.877066687177192	0.877066687177192	55703/10621	2	ENSG00000013503,ENSG00000132664	POLR3B,POLR3F
R-HSA-1482922	Acyl chain remodelling of PI	1/167	12/7349	0.241221437082125	0.877066687177192	0.877066687177192	79887	1	ENSG00000121316	PLBD1
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	1/167	12/7349	0.241221437082125	0.877066687177192	0.877066687177192	145482	1	ENSG00000140043	PTGR2
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	1/167	12/7349	0.241221437082125	0.877066687177192	0.877066687177192	4588	1	ENSG00000184956	MUC6
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	1/167	12/7349	0.241221437082125	0.877066687177192	0.877066687177192	4588	1	ENSG00000184956	MUC6
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	1/167	12/7349	0.241221437082125	0.877066687177192	0.877066687177192	4588	1	ENSG00000184956	MUC6
R-HSA-9018677	Biosynthesis of DHA-derived SPMs	1/167	12/7349	0.241221437082125	0.877066687177192	0.877066687177192	2053	1	ENSG00000120915	EPHX2
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1/167	12/7349	0.241221437082125	0.877066687177192	0.877066687177192	1147	1	ENSG00000213341	CHUK
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	1/167	12/7349	0.241221437082125	0.877066687177192	0.877066687177192	387522	1	ENSG00000124208	TMEM189-UBE2V1
R-HSA-351202	Metabolism of polyamines	3/167	75/7349	0.242560260049422	0.877066687177192	0.877066687177192	262/445/1159	3	ENSG00000123505,ENSG00000130707,ENSG00000237289	AMD1,ASS1,CKMT1B
R-HSA-1483206	Glycerophospholipid biosynthesis	4/167	111/7349	0.245190955004286	0.877066687177192	0.877066687177192	79887/85465/3032/23760	4	ENSG00000121316,ENSG00000138018,ENSG00000138029,ENSG00000180957	PLBD1,EPT1,HADHB,PITPNB
R-HSA-447115	Interleukin-12 family signaling	2/167	42/7349	0.247193024613881	0.877066687177192	0.877066687177192	3313/6845	2	ENSG00000113013,ENSG00000124333	HSPA9,VAMP7
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	2/167	42/7349	0.247193024613881	0.877066687177192	0.877066687177192	79728/4683	2	ENSG00000083093,ENSG00000104320	PALB2,NBN
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	3/167	77/7349	0.254793978852161	0.877066687177192	0.877066687177192	6845/10618/9318	3	ENSG00000124333,ENSG00000152291,ENSG00000166200	VAMP7,TGOLN2,COPS2
R-HSA-198323	AKT phosphorylates targets in the cytosol	1/167	13/7349	0.258492258944915	0.877066687177192	0.877066687177192	1147	1	ENSG00000213341	CHUK
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	1/167	13/7349	0.258492258944915	0.877066687177192	0.877066687177192	1376	1	ENSG00000157184	CPT2
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	1/167	13/7349	0.258492258944915	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	1/167	13/7349	0.258492258944915	0.877066687177192	0.877066687177192	2982	1	ENSG00000164116	GUCY1A3
R-HSA-435354	Zinc transporters	1/167	13/7349	0.258492258944915	0.877066687177192	0.877066687177192	23516	1	ENSG00000104635	SLC39A14
R-HSA-442982	Ras activation upon Ca2+ influx through NMDA receptor	1/167	13/7349	0.258492258944915	0.877066687177192	0.877066687177192	818	1	ENSG00000148660	CAMK2G
R-HSA-5365859	RA biosynthesis pathway	1/167	13/7349	0.258492258944915	0.877066687177192	0.877066687177192	51109	1	ENSG00000072042	RDH11
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1/167	13/7349	0.258492258944915	0.877066687177192	0.877066687177192	4775	1	ENSG00000072736	NFATC3
R-HSA-877312	Regulation of IFNG signaling	1/167	13/7349	0.258492258944915	0.877066687177192	0.877066687177192	3459	1	ENSG00000027697	IFNGR1
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	2/167	44/7349	0.26414763403821	0.877066687177192	0.877066687177192	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-196854	Metabolism of vitamins and cofactors	5/167	154/7349	0.272294958793478	0.877066687177192	0.877066687177192	51109/55034/3417/441024/9963	5	ENSG00000072042,ENSG00000075643,ENSG00000138413,ENSG00000163738,ENSG00000170482	RDH11,MOCOS,IDH1,MTHFD2L,SLC23A1
R-HSA-6802949	Signaling by RAS mutants	2/167	45/7349	0.272629067237278	0.877066687177192	0.877066687177192	153090/161742	2	ENSG00000136848,ENSG00000166068	DAB2IP,SPRED1
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	4/167	117/7349	0.275299930251373	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-196757	Metabolism of folate and pterines	1/167	14/7349	0.275372274315171	0.877066687177192	0.877066687177192	441024	1	ENSG00000163738	MTHFD2L
R-HSA-211976	Endogenous sterols	1/167	14/7349	0.275372274315171	0.877066687177192	0.877066687177192	196	1	ENSG00000106546	AHR
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	1/167	14/7349	0.275372274315171	0.877066687177192	0.877066687177192	8573	1	ENSG00000147044	CASK
R-HSA-2142845	Hyaluronan metabolism	1/167	14/7349	0.275372274315171	0.877066687177192	0.877066687177192	3074	1	ENSG00000049860	HEXB
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	1/167	14/7349	0.275372274315171	0.877066687177192	0.877066687177192	79370	1	ENSG00000121380	BCL2L14
R-HSA-1433559	Regulation of KIT signaling	1/167	15/7349	0.291870274340988	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-189445	Metabolism of porphyrins	1/167	15/7349	0.291870274340988	0.877066687177192	0.877066687177192	54658	1	ENSG00000241635	UGT1A1
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	1/167	15/7349	0.291870274340988	0.877066687177192	0.877066687177192	51109	1	ENSG00000072042	RDH11
R-HSA-5609975	Diseases associated with glycosylation precursor biosynthesis	1/167	15/7349	0.291870274340988	0.877066687177192	0.877066687177192	10020	1	ENSG00000159921	GNE
R-HSA-5683826	Surfactant metabolism	1/167	15/7349	0.291870274340988	0.877066687177192	0.877066687177192	29080	1	ENSG00000133773	CCDC59
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	1/167	15/7349	0.291870274340988	0.877066687177192	0.877066687177192	2182	1	ENSG00000068366	ACSL4
R-HSA-2980736	Peptide hormone metabolism	2/167	48/7349	0.298037554477169	0.877066687177192	0.877066687177192	3799/1803	2	ENSG00000170759,ENSG00000197635	KIF5B,DPP4
R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds	2/167	48/7349	0.298037554477169	0.877066687177192	0.877066687177192	23516/1317	2	ENSG00000104635,ENSG00000136868	SLC39A14,SLC31A1
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	2/167	49/7349	0.306481706204274	0.877066687177192	0.877066687177192	8581/646627	2	ENSG00000167656,ENSG00000259823	LY6D,LYPD8
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	2/167	49/7349	0.306481706204274	0.877066687177192	0.877066687177192	4683/7336	2	ENSG00000104320,ENSG00000169139	NBN,UBE2V2
R-HSA-6799198	Complex I biogenesis	2/167	49/7349	0.306481706204274	0.877066687177192	0.877066687177192	4719/4711	2	ENSG00000023228,ENSG00000136521	NDUFS1,NDUFB5
R-HSA-186712	Regulation of beta-cell development	1/167	16/7349	0.307994853586291	0.877066687177192	0.877066687177192	3174	1	ENSG00000164749	HNF4G
R-HSA-2024096	HS-GAG degradation	1/167	16/7349	0.307994853586291	0.877066687177192	0.877066687177192	10855	1	ENSG00000173083	HPSE
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	1/167	16/7349	0.307994853586291	0.877066687177192	0.877066687177192	2744	1	ENSG00000115419	GLS
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1/167	16/7349	0.307994853586291	0.877066687177192	0.877066687177192	22894	1	ENSG00000083520	DIS3
R-HSA-4641263	Regulation of FZD by ubiquitination	1/167	16/7349	0.307994853586291	0.877066687177192	0.877066687177192	55366	1	ENSG00000205213	LGR4
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	1/167	16/7349	0.307994853586291	0.877066687177192	0.877066687177192	1147	1	ENSG00000213341	CHUK
R-HSA-74259	Purine catabolism	1/167	16/7349	0.307994853586291	0.877066687177192	0.877066687177192	131870	1	ENSG00000198585	NUDT16
R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	2/167	50/7349	0.314906940525255	0.877066687177192	0.877066687177192	3988/4547	2	ENSG00000107798,ENSG00000138823	LIPA,MTTP
R-HSA-3214841	PKMTs methylate histone lysines	2/167	50/7349	0.314906940525255	0.877066687177192	0.877066687177192	121536/64324	2	ENSG00000139154,ENSG00000165671	AEBP2,NSD1
R-HSA-112316	Neuronal System	5/167	164/7349	0.316668329345123	0.877066687177192	0.877066687177192	7915/2744/8573/818/18	5	ENSG00000112294,ENSG00000115419,ENSG00000147044,ENSG00000148660,ENSG00000183044	ALDH5A1,GLS,CASK,CAMK2G,ABAT
R-HSA-202403	TCR signaling	3/167	87/7349	0.316937570309324	0.877066687177192	0.877066687177192	387522/4690/1147	3	ENSG00000124208,ENSG00000158092,ENSG00000213341	TMEM189-UBE2V1,NCK1,CHUK
R-HSA-15869	Metabolism of nucleotides	3/167	88/7349	0.323195952982208	0.877066687177192	0.877066687177192	50484/122481/131870	3	ENSG00000048392,ENSG00000140057,ENSG00000198585	RRM2B,AK7,NUDT16
R-HSA-169911	Regulation of Apoptosis	2/167	51/7349	0.323309772007046	0.877066687177192	0.877066687177192	115209/4976	2	ENSG00000162600,ENSG00000198836	OMA1,OPA1
R-HSA-1592389	Activation of Matrix Metalloproteinases	1/167	17/7349	0.323754414400568	0.877066687177192	0.877066687177192	4312	1	ENSG00000196611	MMP1
R-HSA-2022928	HS-GAG biosynthesis	1/167	17/7349	0.323754414400568	0.877066687177192	0.877066687177192	9957	1	ENSG00000002587	HS3ST1
R-HSA-389513	CTLA4 inhibitory signaling	1/167	17/7349	0.323754414400568	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	1/167	17/7349	0.323754414400568	0.877066687177192	0.877066687177192	22894	1	ENSG00000083520	DIS3
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1/167	17/7349	0.323754414400568	0.877066687177192	0.877066687177192	22894	1	ENSG00000083520	DIS3
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	1/167	17/7349	0.323754414400568	0.877066687177192	0.877066687177192	22894	1	ENSG00000083520	DIS3
R-HSA-5576892	Phase 0 - rapid depolarisation	1/167	17/7349	0.323754414400568	0.877066687177192	0.877066687177192	818	1	ENSG00000148660	CAMK2G
R-HSA-5621575	CD209 (DC-SIGN) signaling	1/167	17/7349	0.323754414400568	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-8964038	LDL clearance	1/167	17/7349	0.323754414400568	0.877066687177192	0.877066687177192	3988	1	ENSG00000107798	LIPA
R-HSA-382556	ABC-family proteins mediated transport	3/167	89/7349	0.329455237661736	0.877066687177192	0.877066687177192	1244/368/11160	3	ENSG00000023839,ENSG00000091262,ENSG00000147475	ABCC2,ABCC6,ERLIN2
R-HSA-380108	Chemokine receptors bind chemokines	1/167	18/7349	0.339157171192044	0.877066687177192	0.877066687177192	51554	1	ENSG00000129048	ACKR4
R-HSA-418990	Adherens junctions interactions	1/167	18/7349	0.339157171192044	0.877066687177192	0.877066687177192	1015	1	ENSG00000079112	CDH17
R-HSA-977068	Termination of O-glycan biosynthesis	1/167	18/7349	0.339157171192044	0.877066687177192	0.877066687177192	4588	1	ENSG00000184956	MUC6
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	2/167	53/7349	0.340035110335892	0.877066687177192	0.877066687177192	4683/7336	2	ENSG00000104320,ENSG00000169139	NBN,UBE2V2
R-HSA-168898	Toll-Like Receptors Cascades	4/167	131/7349	0.34741605822374	0.877066687177192	0.877066687177192	5601/4208/387522/1147	4	ENSG00000050748,ENSG00000081189,ENSG00000124208,ENSG00000213341	MAPK9,MEF2C,TMEM189-UBE2V1,CHUK
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	2/167	54/7349	0.34835145506716	0.877066687177192	0.877066687177192	4208/133522	2	ENSG00000081189,ENSG00000155846	MEF2C,PPARGC1B
R-HSA-5693606	DNA Double Strand Break Response	2/167	54/7349	0.34835145506716	0.877066687177192	0.877066687177192	4683/7336	2	ENSG00000104320,ENSG00000169139	NBN,UBE2V2
R-HSA-110320	Translesion Synthesis by POLH	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	25898	1	ENSG00000163743	RCHY1
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	996	1	ENSG00000004897	CDC27
R-HSA-176412	Phosphorylation of the APC/C	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	996	1	ENSG00000004897	CDC27
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	6342	1	ENSG00000116171	SCP2
R-HSA-264876	Insulin processing	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	3799	1	ENSG00000170759	KIF5B
R-HSA-399719	Trafficking of AMPA receptors	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	818	1	ENSG00000148660	CAMK2G
R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	818	1	ENSG00000148660	CAMK2G
R-HSA-420029	Tight junction interactions	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	64398	1	ENSG00000072415	MPP5
R-HSA-5260271	Diseases of Immune System	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	1147	1	ENSG00000213341	CHUK
R-HSA-5602358	Diseases associated with the TLR signaling cascade	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	1147	1	ENSG00000213341	CHUK
R-HSA-982772	Growth hormone receptor signaling	1/167	19/7349	0.354211154606439	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-72187	mRNA 3'-end processing	2/167	56/7349	0.364877221513811	0.877066687177192	0.877066687177192	57187/51362	2	ENSG00000125676,ENSG00000168438	THOC2,CDC40
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	1/167	20/7349	0.368924215613359	0.877066687177192	0.877066687177192	996	1	ENSG00000004897	CDC27
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	1/167	20/7349	0.368924215613359	0.877066687177192	0.877066687177192	996	1	ENSG00000004897	CDC27
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	1/167	20/7349	0.368924215613359	0.877066687177192	0.877066687177192	1147	1	ENSG00000213341	CHUK
R-HSA-375276	Peptide ligand-binding receptors	2/167	57/7349	0.373081364251958	0.877066687177192	0.877066687177192	51554/84109	2	ENSG00000129048,ENSG00000186867	ACKR4,QRFPR
R-HSA-5607764	CLEC7A (Dectin-1) signaling	3/167	97/7349	0.379371198097062	0.877066687177192	0.877066687177192	4775/387522/1147	3	ENSG00000072736,ENSG00000124208,ENSG00000213341	NFATC3,TMEM189-UBE2V1,CHUK
R-HSA-3000170	Syndecan interactions	1/167	21/7349	0.383304029502371	0.877066687177192	0.877066687177192	8573	1	ENSG00000147044	CASK
R-HSA-3371571	HSF1-dependent transactivation	1/167	21/7349	0.383304029502371	0.877066687177192	0.877066687177192	818	1	ENSG00000148660	CAMK2G
R-HSA-375170	CDO in myogenesis	1/167	21/7349	0.383304029502371	0.877066687177192	0.877066687177192	4208	1	ENSG00000081189	MEF2C
R-HSA-379726	Mitochondrial tRNA aminoacylation	1/167	21/7349	0.383304029502371	0.877066687177192	0.877066687177192	124454	1	ENSG00000103356	EARS2
R-HSA-525793	Myogenesis	1/167	21/7349	0.383304029502371	0.877066687177192	0.877066687177192	4208	1	ENSG00000081189	MEF2C
R-HSA-8949215	Mitochondrial calcium ion transport	1/167	21/7349	0.383304029502371	0.877066687177192	0.877066687177192	8165	1	ENSG00000121057	AKAP1
R-HSA-8978934	Metabolism of cofactors	1/167	21/7349	0.383304029502371	0.877066687177192	0.877066687177192	3417	1	ENSG00000138413	IDH1
R-HSA-912631	Regulation of signaling by CBL	1/167	21/7349	0.383304029502371	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	3/167	98/7349	0.385568587869197	0.877066687177192	0.877066687177192	51554/8477/84109	3	ENSG00000129048,ENSG00000140030,ENSG00000186867	ACKR4,GPR65,QRFPR
R-HSA-1482788	Acyl chain remodelling of PC	1/167	22/7349	0.397358099790731	0.877066687177192	0.877066687177192	79887	1	ENSG00000121316	PLBD1
R-HSA-166208	mTORC1-mediated signalling	1/167	22/7349	0.397358099790731	0.877066687177192	0.877066687177192	29904	1	ENSG00000103319	EEF2K
R-HSA-1839124	FGFR1 mutant receptor activation	1/167	22/7349	0.397358099790731	0.877066687177192	0.877066687177192	11160	1	ENSG00000147475	ERLIN2
R-HSA-198753	ERK/MAPK targets	1/167	22/7349	0.397358099790731	0.877066687177192	0.877066687177192	4208	1	ENSG00000081189	MEF2C
R-HSA-5627123	RHO GTPases activate PAKs	1/167	22/7349	0.397358099790731	0.877066687177192	0.877066687177192	4638	1	ENSG00000065534	MYLK
R-HSA-933542	TRAF6 mediated NF-kB activation	1/167	22/7349	0.397358099790731	0.877066687177192	0.877066687177192	1147	1	ENSG00000213341	CHUK
R-HSA-2219528	PI3K/AKT Signaling in Cancer	2/167	60/7349	0.39742998518913	0.877066687177192	0.877066687177192	118788/1147	2	ENSG00000155629,ENSG00000213341	PIK3AP1,CHUK
R-HSA-446728	Cell junction organization	2/167	60/7349	0.39742998518913	0.877066687177192	0.877066687177192	64398/1015	2	ENSG00000072415,ENSG00000079112	MPP5,CDH17
R-HSA-3781865	Diseases of glycosylation	3/167	102/7349	0.410205685903464	0.877066687177192	0.877066687177192	3074/10020/4588	3	ENSG00000049860,ENSG00000159921,ENSG00000184956	HEXB,GNE,MUC6
R-HSA-1482839	Acyl chain remodelling of PE	1/167	23/7349	0.411093762044716	0.877066687177192	0.877066687177192	79887	1	ENSG00000121316	PLBD1
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	1/167	23/7349	0.411093762044716	0.877066687177192	0.877066687177192	1147	1	ENSG00000213341	CHUK
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	1/167	23/7349	0.411093762044716	0.877066687177192	0.877066687177192	996	1	ENSG00000004897	CDC27
R-HSA-442742	CREB phosphorylation through the activation of Ras	1/167	23/7349	0.411093762044716	0.877066687177192	0.877066687177192	818	1	ENSG00000148660	CAMK2G
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	1/167	23/7349	0.411093762044716	0.877066687177192	0.877066687177192	387522	1	ENSG00000124208	TMEM189-UBE2V1
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	1/167	24/7349	0.424518187616452	0.877066687177192	0.877066687177192	51196	1	ENSG00000138193	PLCE1
R-HSA-380994	ATF4 activates genes	1/167	24/7349	0.424518187616452	0.877066687177192	0.877066687177192	22894	1	ENSG00000083520	DIS3
R-HSA-3928663	EPHA-mediated growth cone collapse	1/167	24/7349	0.424518187616452	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	1/167	24/7349	0.424518187616452	0.877066687177192	0.877066687177192	1147	1	ENSG00000213341	CHUK
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	7/167	273/7349	0.42729156572738	0.877066687177192	0.877066687177192	996/387522/25847/7326/7428/25898/7336	7	ENSG00000004897,ENSG00000124208,ENSG00000129055,ENSG00000132388,ENSG00000134086,ENSG00000163743,ENSG00000169139	CDC27,TMEM189-UBE2V1,ANAPC13,UBE2G1,VHL,RCHY1,UBE2V2
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	3/167	105/7349	0.428489402957231	0.877066687177192	0.877066687177192	55034/441024/9963	3	ENSG00000075643,ENSG00000163738,ENSG00000170482	MOCOS,MTHFD2L,SLC23A1
R-HSA-1989781	PPARA activates gene expression	3/167	105/7349	0.428489402957231	0.877066687177192	0.877066687177192	196/133522/1376	3	ENSG00000106546,ENSG00000155846,ENSG00000157184	AHR,PPARGC1B,CPT2
R-HSA-1268020	Mitochondrial protein import	2/167	64/7349	0.429201146049474	0.877066687177192	0.877066687177192	3313/26515	2	ENSG00000113013,ENSG00000132286	HSPA9,TIMM10B
R-HSA-416476	G alpha (q) signalling events	3/167	106/7349	0.434540942391975	0.877066687177192	0.877066687177192	5998/8477/84109	3	ENSG00000138835,ENSG00000140030,ENSG00000186867	RGS3,GPR65,QRFPR
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	2/167	65/7349	0.437007842821878	0.877066687177192	0.877066687177192	57187/51362	2	ENSG00000125676,ENSG00000168438	THOC2,CDC40
R-HSA-5658442	Regulation of RAS by GAPs	2/167	65/7349	0.437007842821878	0.877066687177192	0.877066687177192	153090/161742	2	ENSG00000136848,ENSG00000166068	DAB2IP,SPRED1
R-HSA-73856	RNA Polymerase II Transcription Termination	2/167	65/7349	0.437007842821878	0.877066687177192	0.877066687177192	57187/51362	2	ENSG00000125676,ENSG00000168438	THOC2,CDC40
R-HSA-114604	GPVI-mediated activation cascade	1/167	25/7349	0.437638387298097	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	1/167	25/7349	0.437638387298097	0.877066687177192	0.877066687177192	996	1	ENSG00000004897	CDC27
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	1/167	25/7349	0.437638387298097	0.877066687177192	0.877066687177192	4208	1	ENSG00000081189	MEF2C
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	1/167	25/7349	0.437638387298097	0.877066687177192	0.877066687177192	3074	1	ENSG00000049860	HEXB
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	3/167	107/7349	0.440569200248109	0.877066687177192	0.877066687177192	196/133522/1376	3	ENSG00000106546,ENSG00000155846,ENSG00000157184	AHR,PPARGC1B,CPT2
R-HSA-5685942	HDR through Homologous Recombination (HRR)	2/167	66/7349	0.444756915770675	0.877066687177192	0.877066687177192	79728/4683	2	ENSG00000083093,ENSG00000104320	PALB2,NBN
R-HSA-192105	Synthesis of bile acids and bile salts	1/167	26/7349	0.450461214895205	0.877066687177192	0.877066687177192	6342	1	ENSG00000116171	SCP2
R-HSA-2129379	Molecules associated with elastic fibres	1/167	26/7349	0.450461214895205	0.877066687177192	0.877066687177192	84034	1	ENSG00000132205	EMILIN2
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	1/167	26/7349	0.450461214895205	0.877066687177192	0.877066687177192	23443	1	ENSG00000117620	SLC35A3
R-HSA-5626467	RHO GTPases activate IQGAPs	1/167	26/7349	0.450461214895205	0.877066687177192	0.877066687177192	10788	1	ENSG00000145703	IQGAP2
R-HSA-5689901	Metalloprotease DUBs	1/167	26/7349	0.450461214895205	0.877066687177192	0.877066687177192	23172	1	ENSG00000165660	FAM175B
R-HSA-75105	Fatty acyl-CoA biosynthesis	1/167	26/7349	0.450461214895205	0.877066687177192	0.877066687177192	2182	1	ENSG00000068366	ACSL4
R-HSA-975634	Retinoid metabolism and transport	1/167	26/7349	0.450461214895205	0.877066687177192	0.877066687177192	51109	1	ENSG00000072042	RDH11
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	3/167	110/7349	0.458504361834922	0.877066687177192	0.877066687177192	79728/4683/7336	3	ENSG00000083093,ENSG00000104320,ENSG00000169139	PALB2,NBN,UBE2V2
R-HSA-8852135	Protein ubiquitination	2/167	68/7349	0.460076604768666	0.877066687177192	0.877066687177192	7326/7336	2	ENSG00000132388,ENSG00000169139	UBE2G1,UBE2V2
R-HSA-983169	Class I MHC mediated antigen processing & presentation	8/167	325/7349	0.46037374036554	0.877066687177192	0.877066687177192	996/387522/25847/7326/7428/25898/7336/1147	8	ENSG00000004897,ENSG00000124208,ENSG00000129055,ENSG00000132388,ENSG00000134086,ENSG00000163743,ENSG00000169139,ENSG00000213341	CDC27,TMEM189-UBE2V1,ANAPC13,UBE2G1,VHL,RCHY1,UBE2V2,CHUK
R-HSA-186763	Downstream signal transduction	1/167	27/7349	0.462993370721028	0.877066687177192	0.877066687177192	4690	1	ENSG00000158092	NCK1
R-HSA-381042	PERK regulates gene expression	1/167	27/7349	0.462993370721028	0.877066687177192	0.877066687177192	22894	1	ENSG00000083520	DIS3
R-HSA-389356	CD28 co-stimulation	1/167	27/7349	0.462993370721028	0.877066687177192	0.877066687177192	4067	1	ENSG00000254087	LYN
R-HSA-438064	Post NMDA receptor activation events	1/167	27/7349	0.462993370721028	0.877066687177192	0.877066687177192	818	1	ENSG00000148660	CAMK2G
R-HSA-445355	Smooth Muscle Contraction	1/167	27/7349	0.462993370721028	0.877066687177192	0.877066687177192	4638	1	ENSG00000065534	MYLK
R-HSA-73728	RNA Polymerase I Promoter Opening	1/167	27/7349	0.462993370721028	0.877066687177192	0.877066687177192	8932	1	ENSG00000134046	MBD2
R-HSA-8964043	Plasma lipoprotein clearance	1/167	27/7349	0.462993370721028	0.877066687177192	0.877066687177192	3988	1	ENSG00000107798	LIPA
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	2/167	69/7349	0.467644658010022	0.88254743729711	0.88254743729711	57187/51362	2	ENSG00000125676,ENSG00000168438	THOC2,CDC40
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	2/167	70/7349	0.475149954992176	0.886881729802172	0.886881729802172	4690/4067	2	ENSG00000158092,ENSG00000254087	NCK1,LYN
R-HSA-442755	Activation of NMDA receptor and postsynaptic events	1/167	28/7349	0.475241405013514	0.886881729802172	0.886881729802172	818	1	ENSG00000148660	CAMK2G
R-HSA-8956319	Nucleobase catabolism	1/167	28/7349	0.475241405013514	0.886881729802172	0.886881729802172	131870	1	ENSG00000198585	NUDT16
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	1/167	29/7349	0.487211721276695	0.891292209726524	0.891292209726524	1147	1	ENSG00000213341	CHUK
R-HSA-5655302	Signaling by FGFR1 in disease	1/167	29/7349	0.487211721276695	0.891292209726524	0.891292209726524	11160	1	ENSG00000147475	ERLIN2
R-HSA-6794361	Neurexins and neuroligins	1/167	29/7349	0.487211721276695	0.891292209726524	0.891292209726524	8573	1	ENSG00000147044	CASK
R-HSA-6806667	Metabolism of fat-soluble vitamins	1/167	29/7349	0.487211721276695	0.891292209726524	0.891292209726524	51109	1	ENSG00000072042	RDH11
R-HSA-449147	Signaling by Interleukins	8/167	333/7349	0.487983920254919	0.891292209726524	0.891292209726524	5601/4208/3313/387522/6845/4312/1147/4067	8	ENSG00000050748,ENSG00000081189,ENSG00000113013,ENSG00000124208,ENSG00000124333,ENSG00000196611,ENSG00000213341,ENSG00000254087	MAPK9,MEF2C,HSPA9,TMEM189-UBE2V1,VAMP7,MMP1,CHUK,LYN
R-HSA-5693538	Homology Directed Repair	3/167	116/7349	0.493620108839977	0.891292209726524	0.891292209726524	79728/4683/7336	3	ENSG00000083093,ENSG00000104320,ENSG00000169139	PALB2,NBN,UBE2V2
R-HSA-8856828	Clathrin-mediated endocytosis	3/167	116/7349	0.493620108839977	0.891292209726524	0.891292209726524	6845/10618/9318	3	ENSG00000124333,ENSG00000152291,ENSG00000166200	VAMP7,TGOLN2,COPS2
R-HSA-73854	RNA Polymerase I Promoter Clearance	2/167	73/7349	0.497279039397537	0.891292209726524	0.891292209726524	54700/8932	2	ENSG00000085721,ENSG00000134046	RRN3,MBD2
R-HSA-194068	Bile acid and bile salt metabolism	1/167	30/7349	0.498910579548114	0.891292209726524	0.891292209726524	6342	1	ENSG00000116171	SCP2
R-HSA-5663084	Diseases of carbohydrate metabolism	1/167	30/7349	0.498910579548114	0.891292209726524	0.891292209726524	2799	1	ENSG00000135677	GNS
R-HSA-73772	RNA Polymerase I Promoter Escape	1/167	30/7349	0.498910579548114	0.891292209726524	0.891292209726524	54700	1	ENSG00000085721	RRN3
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	1/167	30/7349	0.498910579548114	0.891292209726524	0.891292209726524	7326	1	ENSG00000132388	UBE2G1
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	1/167	31/7349	0.510344099593949	0.899663809432167	0.899663809432167	4690	1	ENSG00000158092	NCK1
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	1/167	31/7349	0.510344099593949	0.899663809432167	0.899663809432167	3313	1	ENSG00000113013	HSPA9
R-HSA-69473	G2/M DNA damage checkpoint	2/167	75/7349	0.511700504055452	0.899663809432167	0.899663809432167	4683/7336	2	ENSG00000104320,ENSG00000169139	NBN,UBE2V2
R-HSA-73864	RNA Polymerase I Transcription	2/167	75/7349	0.511700504055452	0.899663809432167	0.899663809432167	54700/8932	2	ENSG00000085721,ENSG00000134046	RRN3,MBD2
R-HSA-202424	Downstream TCR signaling	2/167	76/7349	0.518809563328535	0.899663809432167	0.899663809432167	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-1566948	Elastic fibre formation	1/167	32/7349	0.521518264033387	0.899663809432167	0.899663809432167	84034	1	ENSG00000132205	EMILIN2
R-HSA-5357905	Regulation of TNFR1 signaling	1/167	32/7349	0.521518264033387	0.899663809432167	0.899663809432167	1147	1	ENSG00000213341	CHUK
R-HSA-5362517	Signaling by Retinoic Acid	1/167	32/7349	0.521518264033387	0.899663809432167	0.899663809432167	51109	1	ENSG00000072042	RDH11
R-HSA-5578775	Ion homeostasis	1/167	32/7349	0.521518264033387	0.899663809432167	0.899663809432167	818	1	ENSG00000148660	CAMK2G
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	1/167	32/7349	0.521518264033387	0.899663809432167	0.899663809432167	3032	1	ENSG00000138029	HADHB
R-HSA-5693607	Processing of DNA double-strand break ends	2/167	77/7349	0.525849978914571	0.904029758270941	0.904029758270941	4683/7336	2	ENSG00000104320,ENSG00000169139	NBN,UBE2V2
R-HSA-1442490	Collagen degradation	1/167	33/7349	0.532438921393839	0.906699099946391	0.906699099946391	4312	1	ENSG00000196611	MMP1
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	2/167	78/7349	0.532821184231445	0.906699099946391	0.906699099946391	10618/4312	2	ENSG00000152291,ENSG00000196611	TGOLN2,MMP1
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	2/167	78/7349	0.532821184231445	0.906699099946391	0.906699099946391	57187/51362	2	ENSG00000125676,ENSG00000168438	THOC2,CDC40
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	2/167	79/7349	0.539722673386142	0.909258890146792	0.909258890146792	4775/1147	2	ENSG00000072736,ENSG00000213341	NFATC3,CHUK
R-HSA-428157	Sphingolipid metabolism	2/167	79/7349	0.539722673386142	0.909258890146792	0.909258890146792	3074/8611	2	ENSG00000049860,ENSG00000067113	HEXB,PPAP2A
R-HSA-6804757	Regulation of TP53 Degradation	1/167	34/7349	0.54311178909849	0.909258890146792	0.909258890146792	900	1	ENSG00000113328	CCNG1
R-HSA-936837	Ion transport by P-type ATPases	1/167	34/7349	0.54311178909849	0.909258890146792	0.909258890146792	818	1	ENSG00000148660	CAMK2G
R-HSA-71387	Metabolism of carbohydrates	5/167	215/7349	0.543381806860633	0.909258890146792	0.909258890146792	9957/3074/2799/92126/10855	5	ENSG00000002587,ENSG00000049860,ENSG00000135677,ENSG00000171451,ENSG00000173083	HS3ST1,HEXB,GNS,DSEL,HPSE
R-HSA-5628897	TP53 Regulates Metabolic Genes	2/167	80/7349	0.546553998739871	0.911076436415161	0.911076436415162	50484/2744	2	ENSG00000048392,ENSG00000115419	RRM2B,GLS
R-HSA-5683057	MAPK family signaling cascades	5/167	217/7349	0.551701321586674	0.911076436415161	0.911076436415162	8555/153090/818/161742/148170	5	ENSG00000081377,ENSG00000136848,ENSG00000148660,ENSG00000166068,ENSG00000167617	CDC14B,DAB2IP,CAMK2G,SPRED1,CDC42EP5
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	1/167	35/7349	0.553542456387698	0.911076436415161	0.911076436415162	118788	1	ENSG00000155629	PIK3AP1
R-HSA-5654736	Signaling by FGFR1	1/167	35/7349	0.553542456387698	0.911076436415161	0.911076436415162	161742	1	ENSG00000166068	SPRED1
R-HSA-6806003	Regulation of TP53 Expression and Degradation	1/167	35/7349	0.553542456387698	0.911076436415161	0.911076436415162	900	1	ENSG00000113328	CCNG1
R-HSA-3371556	Cellular response to heat stress	2/167	82/7349	0.560004644696242	0.91427574370677	0.91427574370677	3313/818	2	ENSG00000113013,ENSG00000148660	HSPA9,CAMK2G
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	2/167	82/7349	0.560004644696242	0.91427574370677	0.91427574370677	160518/201475	2	ENSG00000170456,ENSG00000206418	DENND5B,RAB12
R-HSA-383280	Nuclear Receptor transcription pathway	1/167	36/7349	0.563736387175674	0.91427574370677	0.91427574370677	3174	1	ENSG00000164749	HNF4G
R-HSA-5687128	MAPK6/MAPK4 signaling	2/167	83/7349	0.566623340459813	0.91427574370677	0.91427574370677	8555/148170	2	ENSG00000081377,ENSG00000167617	CDC14B,CDC42EP5
R-HSA-1474244	Extracellular matrix organization	4/167	176/7349	0.571012540989852	0.91427574370677	0.91427574370677	4680/84034/8573/4312	4	ENSG00000086548,ENSG00000132205,ENSG00000147044,ENSG00000196611	CEACAM6,EMILIN2,CASK,MMP1
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	2/167	84/7349	0.573170618401883	0.91427574370677	0.91427574370677	9318/7336	2	ENSG00000166200,ENSG00000169139	COPS2,UBE2V2
R-HSA-1433557	Signaling by SCF-KIT	1/167	37/7349	0.573698922843889	0.91427574370677	0.91427574370677	4067	1	ENSG00000254087	LYN
R-HSA-212300	PRC2 methylates histones and DNA	1/167	37/7349	0.573698922843889	0.91427574370677	0.91427574370677	121536	1	ENSG00000139154	AEBP2
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	1/167	37/7349	0.573698922843889	0.91427574370677	0.91427574370677	4067	1	ENSG00000254087	LYN
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	1/167	37/7349	0.573698922843889	0.91427574370677	0.91427574370677	4683	1	ENSG00000104320	NBN
R-HSA-1280215	Cytokine Signaling in Immune system	11/167	495/7349	0.576153645747176	0.915264103300753	0.915264103300753	3459/5601/4208/23321/3313/387522/6845/818/4312/1147/4067	11	ENSG00000027697,ENSG00000050748,ENSG00000081189,ENSG00000109654,ENSG00000113013,ENSG00000124208,ENSG00000124333,ENSG00000148660,ENSG00000196611,ENSG00000213341,ENSG00000254087	IFNGR1,MAPK9,MEF2C,TRIM2,HSPA9,TMEM189-UBE2V1,VAMP7,CAMK2G,MMP1,CHUK,LYN
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	1/167	38/7349	0.583435284972591	0.915264103300753	0.915264103300753	25898	1	ENSG00000163743	RCHY1
R-HSA-165159	mTOR signalling	1/167	38/7349	0.583435284972591	0.915264103300753	0.915264103300753	29904	1	ENSG00000103319	EEF2K
R-HSA-1660661	Sphingolipid de novo biosynthesis	1/167	38/7349	0.583435284972591	0.915264103300753	0.915264103300753	8611	1	ENSG00000067113	PPAP2A
R-HSA-5696394	DNA Damage Recognition in GG-NER	1/167	38/7349	0.583435284972591	0.915264103300753	0.915264103300753	9318	1	ENSG00000166200	COPS2
R-HSA-3928662	EPHB-mediated forward signaling	1/167	39/7349	0.59295057801179	0.924413634043225	0.924413634043225	4067	1	ENSG00000254087	LYN
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	1/167	39/7349	0.59295057801179	0.924413634043225	0.924413634043225	4683	1	ENSG00000104320	NBN
R-HSA-186797	Signaling by PDGF	1/167	40/7349	0.602249791893052	0.931290250942132	0.931290250942132	4690	1	ENSG00000158092	NCK1
R-HSA-1483257	Phospholipid metabolism	4/167	184/7349	0.606412358606573	0.931290250942132	0.931290250942132	79887/85465/3032/23760	4	ENSG00000121316,ENSG00000138018,ENSG00000138029,ENSG00000180957	PLBD1,EPT1,HADHB,PITPNB
R-HSA-109582	Hemostasis	9/167	416/7349	0.609728089370492	0.931290250942132	0.931290250942132	11136/4680/2734/8165/139322/2982/3799/4312/4067	9	ENSG00000021488,ENSG00000086548,ENSG00000090863,ENSG00000121057,ENSG00000155008,ENSG00000164116,ENSG00000170759,ENSG00000196611,ENSG00000254087	SLC7A9,CEACAM6,GLG1,AKAP1,APOOL,GUCY1A3,KIF5B,MMP1,LYN
R-HSA-611105	Respiratory electron transport	2/167	90/7349	0.610946917064	0.931290250942132	0.931290250942132	4719/4711	2	ENSG00000023228,ENSG00000136521	NDUFS1,NDUFB5
R-HSA-1660662	Glycosphingolipid metabolism	1/167	41/7349	0.611337804583415	0.931290250942132	0.931290250942132	3074	1	ENSG00000049860	HEXB
R-HSA-6811438	Intra-Golgi traffic	1/167	41/7349	0.611337804583415	0.931290250942132	0.931290250942132	9527	1	ENSG00000108587	GOSR1
R-HSA-3000171	Non-integrin membrane-ECM interactions	1/167	42/7349	0.620219384582672	0.931290250942132	0.931290250942132	8573	1	ENSG00000147044	CASK
R-HSA-379724	tRNA Aminoacylation	1/167	42/7349	0.620219384582672	0.931290250942132	0.931290250942132	124454	1	ENSG00000103356	EARS2
R-HSA-388841	Costimulation by the CD28 family	1/167	42/7349	0.620219384582672	0.931290250942132	0.931290250942132	4067	1	ENSG00000254087	LYN
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	1/167	42/7349	0.620219384582672	0.931290250942132	0.931290250942132	4067	1	ENSG00000254087	LYN
R-HSA-75893	TNF signaling	1/167	42/7349	0.620219384582672	0.931290250942132	0.931290250942132	1147	1	ENSG00000213341	CHUK
R-HSA-500792	GPCR ligand binding	3/167	141/7349	0.626249259973242	0.931290250942132	0.931290250942132	51554/8477/84109	3	ENSG00000129048,ENSG00000140030,ENSG00000186867	ACKR4,GPR65,QRFPR
R-HSA-5693532	DNA Double-Strand Break Repair	3/167	141/7349	0.626249259973242	0.931290250942132	0.931290250942132	79728/4683/7336	3	ENSG00000083093,ENSG00000104320,ENSG00000169139	PALB2,NBN,UBE2V2
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	1/167	43/7349	0.628899193365304	0.931290250942132	0.931290250942132	79370	1	ENSG00000121380	BCL2L14
R-HSA-5696395	Formation of Incision Complex in GG-NER	1/167	43/7349	0.628899193365304	0.931290250942132	0.931290250942132	7336	1	ENSG00000169139	UBE2V2
R-HSA-69231	Cyclin D associated events in G1	1/167	43/7349	0.628899193365304	0.931290250942132	0.931290250942132	4067	1	ENSG00000254087	LYN
R-HSA-69236	G1 Phase	1/167	43/7349	0.628899193365304	0.931290250942132	0.931290250942132	4067	1	ENSG00000254087	LYN
R-HSA-6794362	Protein-protein interactions at synapses	1/167	44/7349	0.63738178776826	0.941075463116666	0.941075463116666	8573	1	ENSG00000147044	CASK
R-HSA-9006931	Signaling by Nuclear Receptors	3/167	145/7349	0.645143000838125	0.947740217565914	0.947740217565914	51109/9166/1105	3	ENSG00000072042,ENSG00000147654,ENSG00000153922	RDH11,EBAG9,CHD1
R-HSA-983189	Kinesins	1/167	45/7349	0.645671622325782	0.947740217565914	0.947740217565914	3799	1	ENSG00000170759	KIF5B
R-HSA-9020702	Interleukin-1 signaling	2/167	97/7349	0.651755868566934	0.949301321778781	0.949301321778781	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	1/167	46/7349	0.653773051552452	0.949301321778781	0.949301321778781	4588	1	ENSG00000184956	MUC6
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	1/167	47/7349	0.661690332175585	0.949301321778781	0.949301321778781	10618	1	ENSG00000152291	TGOLN2
R-HSA-73762	RNA Polymerase I Transcription Initiation	1/167	47/7349	0.661690332175585	0.949301321778781	0.949301321778781	54700	1	ENSG00000085721	RRN3
R-HSA-73893	DNA Damage Bypass	1/167	47/7349	0.661690332175585	0.949301321778781	0.949301321778781	25898	1	ENSG00000163743	RCHY1
R-HSA-912446	Meiotic recombination	1/167	47/7349	0.661690332175585	0.949301321778781	0.949301321778781	4683	1	ENSG00000104320	NBN
R-HSA-917937	Iron uptake and transport	1/167	47/7349	0.661690332175585	0.949301321778781	0.949301321778781	9429	1	ENSG00000118777	ABCG2
R-HSA-397014	Muscle contraction	2/167	99/7349	0.662776683040363	0.949301321778781	0.949301321778781	4638/818	2	ENSG00000065534,ENSG00000148660	MYLK,CAMK2G
R-HSA-2559583	Cellular Senescence	3/167	150/7349	0.667806295900549	0.949301321778781	0.949301321778781	996/5601/4683	3	ENSG00000004897,ENSG00000050748,ENSG00000104320	CDC27,MAPK9,NBN
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	1/167	48/7349	0.669427625318104	0.949301321778781	0.949301321778781	4690	1	ENSG00000158092	NCK1
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1/167	48/7349	0.669427625318104	0.949301321778781	0.949301321778781	8669	1	ENSG00000104131	EIF3J
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	1/167	48/7349	0.669427625318104	0.949301321778781	0.949301321778781	7336	1	ENSG00000169139	UBE2V2
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	1/167	49/7349	0.676988998632976	0.954630554252118	0.954630554252118	4683	1	ENSG00000104320	NBN
R-HSA-913709	O-linked glycosylation of mucins	1/167	49/7349	0.676988998632976	0.954630554252118	0.954630554252118	4588	1	ENSG00000184956	MUC6
R-HSA-913531	Interferon Signaling	3/167	153/7349	0.680893504441812	0.95744688859885	0.95744688859885	3459/23321/818	3	ENSG00000027697,ENSG00000109654,ENSG00000148660	IFNGR1,TRIM2,CAMK2G
R-HSA-1226099	Signaling by FGFR in disease	1/167	50/7349	0.684378428390276	0.959659137016532	0.959659137016532	11160	1	ENSG00000147475	ERLIN2
R-HSA-6802952	Signaling by BRAF and RAF fusions	1/167	52/7349	0.698656917597209	0.976162355757994	0.976162355757994	55109	1	ENSG00000164252	AGGF1
R-HSA-9018519	Estrogen-dependent gene expression	2/167	108/7349	0.708947580138468	0.976162355757994	0.976162355757994	9166/1105	2	ENSG00000147654,ENSG00000153922	EBAG9,CHD1
R-HSA-418346	Platelet homeostasis	1/167	54/7349	0.712293151865596	0.976162355757994	0.976162355757994	2982	1	ENSG00000164116	GUCY1A3
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1/167	54/7349	0.712293151865596	0.976162355757994	0.976162355757994	9318	1	ENSG00000166200	COPS2
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	2/167	109/7349	0.713740023330289	0.976162355757994	0.976162355757994	4719/4711	2	ENSG00000023228,ENSG00000136521	NDUFS1,NDUFB5
R-HSA-983712	Ion channel transport	2/167	110/7349	0.718466609654278	0.976162355757994	0.976162355757994	1181/818	2	ENSG00000114859,ENSG00000148660	CLCN2,CAMK2G
R-HSA-2187338	Visual phototransduction	1/167	55/7349	0.718879449828371	0.976162355757994	0.976162355757994	51109	1	ENSG00000072042	RDH11
R-HSA-72649	Translation initiation complex formation	1/167	55/7349	0.718879449828371	0.976162355757994	0.976162355757994	8669	1	ENSG00000104131	EIF3J
R-HSA-72702	Ribosomal scanning and start codon recognition	1/167	55/7349	0.718879449828371	0.976162355757994	0.976162355757994	8669	1	ENSG00000104131	EIF3J
R-HSA-8873719	RAB geranylgeranylation	1/167	55/7349	0.718879449828371	0.976162355757994	0.976162355757994	201475	1	ENSG00000206418	RAB12
R-HSA-212165	Epigenetic regulation of gene expression	2/167	111/7349	0.723127836725973	0.976162355757994	0.976162355757994	8932/121536	2	ENSG00000134046,ENSG00000139154	MBD2,AEBP2
R-HSA-5696398	Nucleotide Excision Repair	2/167	111/7349	0.723127836725973	0.976162355757994	0.976162355757994	9318/7336	2	ENSG00000166200,ENSG00000169139	COPS2,UBE2V2
R-HSA-9007101	Rab regulation of trafficking	2/167	111/7349	0.723127836725973	0.976162355757994	0.976162355757994	160518/201475	2	ENSG00000170456,ENSG00000206418	DENND5B,RAB12
R-HSA-429914	Deadenylation-dependent mRNA decay	1/167	56/7349	0.725315853979545	0.976162355757994	0.976162355757994	22894	1	ENSG00000083520	DIS3
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1/167	56/7349	0.725315853979545	0.976162355757994	0.976162355757994	8669	1	ENSG00000104131	EIF3J
R-HSA-5663202	Diseases of signal transduction	6/167	315/7349	0.727800369529981	0.976404660241272	0.976404660241272	153090/11160/118788/55109/161742/1147	6	ENSG00000136848,ENSG00000147475,ENSG00000155629,ENSG00000164252,ENSG00000166068,ENSG00000213341	DAB2IP,ERLIN2,PIK3AP1,AGGF1,SPRED1,CHUK
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	1/167	57/7349	0.731605755581824	0.976404660241272	0.976404660241272	1147	1	ENSG00000213341	CHUK
R-HSA-8939211	ESR-mediated signaling	2/167	113/7349	0.732256260113513	0.976404660241272	0.976404660241272	9166/1105	2	ENSG00000147654,ENSG00000153922	EBAG9,CHD1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	1/167	58/7349	0.737752469627056	0.976404660241272	0.976404660241272	1147	1	ENSG00000213341	CHUK
R-HSA-5678895	Defective CFTR causes cystic fibrosis	1/167	58/7349	0.737752469627056	0.976404660241272	0.976404660241272	11160	1	ENSG00000147475	ERLIN2
R-HSA-5358346	Hedgehog ligand biogenesis	1/167	59/7349	0.743759236541373	0.976404660241272	0.976404660241272	85455	1	ENSG00000140323	DISP2
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1/167	60/7349	0.749629223852428	0.976404660241272	0.976404660241272	55623	1	ENSG00000066654	THUMPD1
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	1/167	60/7349	0.749629223852428	0.976404660241272	0.976404660241272	118788	1	ENSG00000155629	PIK3AP1
R-HSA-418555	G alpha (s) signalling events	1/167	61/7349	0.75536552781959	0.976404660241272	0.976404660241272	64108	1	ENSG00000136514	RTP4
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	2/167	119/7349	0.758127873596062	0.976404660241272	0.976404660241272	8165/3799	2	ENSG00000121057,ENSG00000170759	AKAP1,KIF5B
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	1/167	62/7349	0.760971175027895	0.976404660241272	0.976404660241272	7428	1	ENSG00000134086	VHL
R-HSA-2672351	Stimuli-sensing channels	1/167	62/7349	0.760971175027895	0.976404660241272	0.976404660241272	1181	1	ENSG00000114859	CLCN2
R-HSA-446652	Interleukin-1 family signaling	2/167	120/7349	0.762224909970173	0.976404660241272	0.976404660241272	387522/1147	2	ENSG00000124208,ENSG00000213341	TMEM189-UBE2V1,CHUK
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	1/167	63/7349	0.766449123946564	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-5576891	Cardiac conduction	1/167	63/7349	0.766449123946564	0.976404660241272	0.976404660241272	818	1	ENSG00000148660	CAMK2G
R-HSA-1169091	Activation of NF-kappaB in B cells	1/167	64/7349	0.771802266452867	0.976404660241272	0.976404660241272	1147	1	ENSG00000213341	CHUK
R-HSA-5673001	RAF/MAP kinase cascade	3/167	177/7349	0.772033319247777	0.976404660241272	0.976404660241272	153090/818/161742	3	ENSG00000136848,ENSG00000148660,ENSG00000166068	DAB2IP,CAMK2G,SPRED1
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	1/167	65/7349	0.777033429322101	0.976404660241272	0.976404660241272	1147	1	ENSG00000213341	CHUK
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	1/167	65/7349	0.777033429322101	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	1/167	65/7349	0.777033429322101	0.976404660241272	0.976404660241272	3313	1	ENSG00000113013	HSPA9
R-HSA-5358351	Signaling by Hedgehog	2/167	125/7349	0.781823810228475	0.976404660241272	0.976404660241272	85455/25989	2	ENSG00000140323,ENSG00000140474	DISP2,ULK3
R-HSA-199418	Negative regulation of the PI3K/AKT network	1/167	66/7349	0.782145375684431	0.976404660241272	0.976404660241272	118788	1	ENSG00000155629	PIK3AP1
R-HSA-8939902	Regulation of RUNX2 expression and activity	1/167	66/7349	0.782145375684431	0.976404660241272	0.976404660241272	133522	1	ENSG00000155846	PPARGC1B
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	3/167	181/7349	0.784968147114883	0.976404660241272	0.976404660241272	9527/10618/3799	3	ENSG00000108587,ENSG00000152291,ENSG00000170759	GOSR1,TGOLN2,KIF5B
R-HSA-5684996	MAPK1/MAPK3 signaling	3/167	182/7349	0.788106254094332	0.976404660241272	0.976404660241272	153090/818/161742	3	ENSG00000136848,ENSG00000148660,ENSG00000166068	DAB2IP,CAMK2G,SPRED1
R-HSA-73894	DNA Repair	5/167	288/7349	0.790027518705237	0.976404660241272	0.976404660241272	79728/4683/25898/9318/7336	5	ENSG00000083093,ENSG00000104320,ENSG00000163743,ENSG00000166200,ENSG00000169139	PALB2,NBN,RCHY1,COPS2,UBE2V2
R-HSA-190236	Signaling by FGFR	1/167	68/7349	0.792022361698287	0.976404660241272	0.976404660241272	161742	1	ENSG00000166068	SPRED1
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	1/167	69/7349	0.796792622046644	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	1/167	69/7349	0.796792622046644	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	1/167	70/7349	0.801454109974969	0.976404660241272	0.976404660241272	7428	1	ENSG00000134086	VHL
R-HSA-1500620	Meiosis	1/167	70/7349	0.801454109974969	0.976404660241272	0.976404660241272	4683	1	ENSG00000104320	NBN
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	1/167	70/7349	0.801454109974969	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	1/167	70/7349	0.801454109974969	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-187037	Signaling by NTRK1 (TRKA)	1/167	70/7349	0.801454109974969	0.976404660241272	0.976404660241272	4208	1	ENSG00000081189	MEF2C
R-HSA-2262749	Cellular response to hypoxia	1/167	70/7349	0.801454109974969	0.976404660241272	0.976404660241272	7428	1	ENSG00000134086	VHL
R-HSA-400253	Circadian Clock	1/167	70/7349	0.801454109974969	0.976404660241272	0.976404660241272	4208	1	ENSG00000081189	MEF2C
R-HSA-427413	NoRC negatively regulates rRNA expression	1/167	70/7349	0.801454109974969	0.976404660241272	0.976404660241272	8932	1	ENSG00000134046	MBD2
R-HSA-8957275	Post-translational protein phosphorylation	1/167	70/7349	0.801454109974969	0.976404660241272	0.976404660241272	10618	1	ENSG00000152291	TGOLN2
R-HSA-112314	Neurotransmitter receptors and postsynaptic signal transmission	1/167	71/7349	0.806009291130922	0.976404660241272	0.976404660241272	818	1	ENSG00000148660	CAMK2G
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	1/167	71/7349	0.806009291130922	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-6785807	Interleukin-4 and 13 signaling	1/167	71/7349	0.806009291130922	0.976404660241272	0.976404660241272	4312	1	ENSG00000196611	MMP1
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	1/167	72/7349	0.810460575602087	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	1/167	73/7349	0.814810319160483	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	1/167	73/7349	0.814810319160483	0.976404660241272	0.976404660241272	8932	1	ENSG00000134046	MBD2
R-HSA-1483255	PI Metabolism	1/167	74/7349	0.819060824479367	0.976404660241272	0.976404660241272	23760	1	ENSG00000180957	PITPNB
R-HSA-5632684	Hedgehog 'on' state	1/167	75/7349	0.823214342322934	0.976404660241272	0.976404660241272	25989	1	ENSG00000140474	ULK3
R-HSA-2262752	Cellular responses to stress	6/167	356/7349	0.826707985543134	0.976404660241272	0.976404660241272	996/5601/4683/3313/7428/818	6	ENSG00000004897,ENSG00000050748,ENSG00000104320,ENSG00000113013,ENSG00000134086,ENSG00000148660	CDC27,MAPK9,NBN,HSPA9,VHL,CAMK2G
R-HSA-1236974	ER-Phagosome pathway	1/167	77/7349	0.831239166048933	0.976404660241272	0.976404660241272	1147	1	ENSG00000213341	CHUK
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	1/167	77/7349	0.831239166048933	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-1474228	Degradation of the extracellular matrix	1/167	78/7349	0.835114724254355	0.976404660241272	0.976404660241272	4312	1	ENSG00000196611	MMP1
R-HSA-1474165	Reproduction	1/167	79/7349	0.838901801829588	0.976404660241272	0.976404660241272	4683	1	ENSG00000104320	NBN
R-HSA-2682334	EPH-Ephrin signaling	1/167	79/7349	0.838901801829588	0.976404660241272	0.976404660241272	4067	1	ENSG00000254087	LYN
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1/167	79/7349	0.838901801829588	0.976404660241272	0.976404660241272	9318	1	ENSG00000166200	COPS2
R-HSA-195258	RHO GTPase Effectors	4/167	256/7349	0.839706051740368	0.976404660241272	0.976404660241272	4638/10788/4690/3799	4	ENSG00000065534,ENSG00000145703,ENSG00000158092,ENSG00000170759	MYLK,IQGAP2,NCK1,KIF5B
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	1/167	80/7349	0.84260240693199	0.976404660241272	0.976404660241272	1147	1	ENSG00000213341	CHUK
R-HSA-69481	G2/M Checkpoints	2/167	145/7349	0.846753459956807	0.976404660241272	0.976404660241272	4683/7336	2	ENSG00000104320,ENSG00000169139	NBN,UBE2V2
R-HSA-5173105	O-linked glycosylation	1/167	82/7349	0.849752006827988	0.976404660241272	0.976404660241272	4588	1	ENSG00000184956	MUC6
R-HSA-8951664	Neddylation	3/167	205/7349	0.850419834920229	0.976404660241272	0.976404660241272	23142/7428/9318	3	ENSG00000109184,ENSG00000134086,ENSG00000166200	DCUN1D4,VHL,COPS2
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	1/167	83/7349	0.853204795442234	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-453276	Regulation of mitotic cell cycle	1/167	83/7349	0.853204795442234	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-166520	Signaling by NTRKs	1/167	84/7349	0.856578701189708	0.976404660241272	0.976404660241272	4208	1	ENSG00000081189	MEF2C
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	1/167	84/7349	0.856578701189708	0.976404660241272	0.976404660241272	3799	1	ENSG00000170759	KIF5B
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	1/167	86/7349	0.863096989870441	0.976404660241272	0.976404660241272	22894	1	ENSG00000083520	DIS3
R-HSA-69052	Switching of origins to a post-replicative state	1/167	86/7349	0.863096989870441	0.976404660241272	0.976404660241272	996	1	ENSG00000004897	CDC27
R-HSA-372790	Signaling by GPCR	6/167	376/7349	0.863460386848371	0.976404660241272	0.976404660241272	51109/51554/64108/5998/8477/84109	6	ENSG00000072042,ENSG00000129048,ENSG00000136514,ENSG00000138835,ENSG00000140030,ENSG00000186867	RDH11,ACKR4,RTP4,RGS3,GPR65,QRFPR
R-HSA-1852241	Organelle biogenesis and maintenance	4/167	269/7349	0.866395047172905	0.976404660241272	0.976404660241272	4208/3313/139322/133522	4	ENSG00000081189,ENSG00000113013,ENSG00000155008,ENSG00000155846	MEF2C,HSPA9,APOOL,PPARGC1B
R-HSA-109581	Apoptosis	2/167	153/7349	0.867435267001288	0.976404660241272	0.976404660241272	115209/4976	2	ENSG00000162600,ENSG00000198836	OMA1,OPA1
R-HSA-5633007	Regulation of TP53 Activity	2/167	153/7349	0.867435267001288	0.976404660241272	0.976404660241272	4683/900	2	ENSG00000104320,ENSG00000113328	NBN,CCNG1
R-HSA-1236975	Antigen processing-Cross presentation	1/167	88/7349	0.869320725386853	0.976404660241272	0.976404660241272	1147	1	ENSG00000213341	CHUK
R-HSA-2559580	Oxidative Stress Induced Senescence	1/167	88/7349	0.869320725386853	0.976404660241272	0.976404660241272	5601	1	ENSG00000050748	MAPK9
R-HSA-4420097	VEGFA-VEGFR2 Pathway	1/167	88/7349	0.869320725386853	0.976404660241272	0.976404660241272	4690	1	ENSG00000158092	NCK1
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	1/167	88/7349	0.869320725386853	0.976404660241272	0.976404660241272	4683	1	ENSG00000104320	NBN
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	2/167	154/7349	0.869833483723582	0.976404660241272	0.976404660241272	4719/4711	2	ENSG00000023228,ENSG00000136521	NDUFS1,NDUFB5
R-HSA-446203	Asparagine N-linked glycosylation	4/167	273/7349	0.873808164286934	0.976404660241272	0.976404660241272	9527/8869/116150/10020	4	ENSG00000108587,ENSG00000115525,ENSG00000153989,ENSG00000159921	GOSR1,ST3GAL5,NUS1,GNE
R-HSA-5357801	Programmed Cell Death	2/167	156/7349	0.87451142190053	0.976404660241272	0.976404660241272	115209/4976	2	ENSG00000162600,ENSG00000198836	OMA1,OPA1
R-HSA-114608	Platelet degranulation 	1/167	90/7349	0.875263141650542	0.976404660241272	0.976404660241272	139322	1	ENSG00000155008	APOOL
R-HSA-6807878	COPI-mediated anterograde transport	1/167	90/7349	0.875263141650542	0.976404660241272	0.976404660241272	9527	1	ENSG00000108587	GOSR1
R-HSA-194138	Signaling by VEGF	1/167	93/7349	0.883676793351484	0.980065461125434	0.980065461125434	4690	1	ENSG00000158092	NCK1
R-HSA-381119	Unfolded Protein Response (UPR)	1/167	93/7349	0.883676793351484	0.980065461125434	0.980065461125434	22894	1	ENSG00000083520	DIS3
R-HSA-72689	Formation of a pool of free 40S subunits	1/167	94/7349	0.886354022611448	0.980065461125434	0.980065461125434	8669	1	ENSG00000104131	EIF3J
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	1/167	94/7349	0.886354022611448	0.980065461125434	0.980065461125434	139322	1	ENSG00000155008	APOOL
R-HSA-5689880	Ub-specific processing proteases	2/167	167/7349	0.897595328171489	0.987658179084812	0.987658179084812	84749/10600	2	ENSG00000135093,ENSG00000156256	USP30,USP16
R-HSA-2132295	MHC class II antigen presentation	1/167	99/7349	0.898848711633905	0.987658179084812	0.987658179084812	3799	1	ENSG00000170759	KIF5B
R-HSA-388396	GPCR downstream signalling	5/167	345/7349	0.899123083350118	0.987658179084812	0.987658179084812	51109/64108/5998/8477/84109	5	ENSG00000072042,ENSG00000136514,ENSG00000138835,ENSG00000140030,ENSG00000186867	RDH11,RTP4,RGS3,GPR65,QRFPR
R-HSA-3700989	Transcriptional Regulation by TP53	5/167	348/7349	0.90318853133569	0.989957735219468	0.989957735219468	50484/4683/900/2744/79370	5	ENSG00000048392,ENSG00000104320,ENSG00000113328,ENSG00000115419,ENSG00000121380	RRM2B,NBN,CCNG1,GLS,BCL2L14
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	1/167	104/7349	0.909977003368535	0.990788426416518	0.990788426416518	8669	1	ENSG00000104131	EIF3J
R-HSA-8878166	Transcriptional regulation by RUNX2	1/167	104/7349	0.909977003368535	0.990788426416518	0.990788426416518	133522	1	ENSG00000155846	PPARGC1B
R-HSA-5688426	Deubiquitination	3/167	237/7349	0.910454728141659	0.990788426416518	0.990788426416518	84749/10600/23172	3	ENSG00000135093,ENSG00000156256,ENSG00000165660	USP30,USP16,FAM175B
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	1/167	105/7349	0.912052067611109	0.990788426416518	0.990788426416518	8669	1	ENSG00000104131	EIF3J
R-HSA-69618	Mitotic Spindle Checkpoint	1/167	110/7349	0.921735421533809	0.990788426416518	0.990788426416518	996	1	ENSG00000004897	CDC27
R-HSA-8953897	Cellular responses to external stimuli	6/167	420/7349	0.922135144708663	0.990788426416518	0.990788426416518	996/5601/4683/3313/7428/818	6	ENSG00000004897,ENSG00000050748,ENSG00000104320,ENSG00000113013,ENSG00000134086,ENSG00000148660	CDC27,MAPK9,NBN,HSPA9,VHL,CAMK2G
R-HSA-76002	Platelet activation, signaling and aggregation	2/167	182/7349	0.922774998142452	0.990788426416518	0.990788426416518	139322/4067	2	ENSG00000155008,ENSG00000254087	APOOL,LYN
R-HSA-194315	Signaling by Rho GTPases	5/167	365/7349	0.923652486874636	0.990788426416518	0.990788426416518	4638/10788/4690/3799/57636	5	ENSG00000065534,ENSG00000145703,ENSG00000158092,ENSG00000170759,ENSG00000275832	MYLK,IQGAP2,NCK1,KIF5B,ARHGAP23
R-HSA-72613	Eukaryotic Translation Initiation	1/167	112/7349	0.925305059729443	0.990788426416518	0.990788426416518	8669	1	ENSG00000104131	EIF3J
R-HSA-72737	Cap-dependent Translation Initiation	1/167	112/7349	0.925305059729443	0.990788426416518	0.990788426416518	8669	1	ENSG00000104131	EIF3J
R-HSA-8868773	rRNA processing in the nucleus and cytosol	2/167	184/7349	0.92565691631344	0.990788426416518	0.990788426416518	55623/22894	2	ENSG00000066654,ENSG00000083520	THUMPD1,DIS3
R-HSA-69239	Synthesis of DNA	1/167	115/7349	0.930358285511473	0.993305582174237	0.993305582174237	996	1	ENSG00000004897	CDC27
R-HSA-8856688	Golgi-to-ER retrograde transport	1/167	116/7349	0.931965994430409	0.993305582174237	0.993305582174237	3799	1	ENSG00000170759	KIF5B
R-HSA-194840	Rho GTPase cycle	1/167	119/7349	0.936571084348019	0.994347020771666	0.994347020771666	57636	1	ENSG00000275832	ARHGAP23
R-HSA-72312	rRNA processing	2/167	194/7349	0.938613278452277	0.994347020771666	0.994347020771666	55623/22894	2	ENSG00000066654,ENSG00000083520	THUMPD1,DIS3
R-HSA-8957322	Metabolism of steroids	1/167	121/7349	0.939467629105547	0.994347020771666	0.994347020771666	6342	1	ENSG00000116171	SCP2
R-HSA-69306	DNA Replication	1/167	122/7349	0.940866204913429	0.994347020771666	0.994347020771666	996	1	ENSG00000004897	CDC27
R-HSA-69620	Cell Cycle Checkpoints	3/167	267/7349	0.946034819518711	0.997045289946846	0.997045289946846	996/4683/7336	3	ENSG00000004897,ENSG00000104320,ENSG00000169139	CDC27,NBN,UBE2V2
R-HSA-73887	Death Receptor Signalling	1/167	127/7349	0.947391640049095	0.997045289946846	0.997045289946846	1147	1	ENSG00000213341	CHUK
R-HSA-1257604	PIP3 activates AKT signaling	2/167	214/7349	0.958403745544053	0.997418590609215	0.997418590609215	118788/1147	2	ENSG00000155629,ENSG00000213341	PIK3AP1,CHUK
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	4/167	348/7349	0.960030293553949	0.997418590609215	0.997418590609215	4208/4690/161742/4067	4	ENSG00000081189,ENSG00000158092,ENSG00000166068,ENSG00000254087	MEF2C,NCK1,SPRED1,LYN
R-HSA-199977	ER to Golgi Anterograde Transport	1/167	141/7349	0.962096567568079	0.997418590609215	0.997418590609215	9527	1	ENSG00000108587	GOSR1
R-HSA-453279	Mitotic G1-G1/S phases	1/167	143/7349	0.963832687079143	0.997418590609215	0.997418590609215	4067	1	ENSG00000254087	LYN
R-HSA-3247509	Chromatin modifying enzymes	2/167	227/7349	0.967830527335866	0.997418590609215	0.997418590609215	121536/64324	2	ENSG00000139154,ENSG00000165671	AEBP2,NSD1
R-HSA-4839726	Chromatin organization	2/167	227/7349	0.967830527335866	0.997418590609215	0.997418590609215	121536/64324	2	ENSG00000139154,ENSG00000165671	AEBP2,NSD1
R-HSA-69242	S Phase	1/167	155/7349	0.972708823397092	0.997418590609215	0.997418590609215	996	1	ENSG00000004897	CDC27
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	2/167	236/7349	0.973119562397295	0.997418590609215	0.997418590609215	57187/51362	2	ENSG00000125676,ENSG00000168438	THOC2,CDC40
R-HSA-9006925	Intracellular signaling by second messengers	2/167	237/7349	0.973652880135641	0.997418590609215	0.997418590609215	118788/1147	2	ENSG00000155629,ENSG00000213341	PIK3AP1,CHUK
R-HSA-948021	Transport to the Golgi and subsequent modification	1/167	165/7349	0.978424898806097	0.997418590609215	0.997418590609215	9527	1	ENSG00000108587	GOSR1
R-HSA-201681	TCF dependent signaling in response to WNT	1/167	170/7349	0.980819310621639	0.997418590609215	0.997418590609215	55366	1	ENSG00000205213	LGR4
R-HSA-418594	G alpha (i) signalling events	1/167	170/7349	0.980819310621639	0.997418590609215	0.997418590609215	51109	1	ENSG00000072042	RDH11
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	1/167	174/7349	0.982543089670196	0.997418590609215	0.997418590609215	22894	1	ENSG00000083520	DIS3
R-HSA-8878171	Transcriptional regulation by RUNX1	1/167	174/7349	0.982543089670196	0.997418590609215	0.997418590609215	122809	1	ENSG00000180008	SOCS4
R-HSA-2467813	Separation of Sister Chromatids	1/167	180/7349	0.984844200178076	0.997418590609215	0.997418590609215	996	1	ENSG00000004897	CDC27
R-HSA-72163	mRNA Splicing - Major Pathway	1/167	180/7349	0.984844200178076	0.997418590609215	0.997418590609215	51362	1	ENSG00000168438	CDC40
R-HSA-72172	mRNA Splicing	1/167	188/7349	0.987449917385637	0.997418590609215	0.997418590609215	51362	1	ENSG00000168438	CDC40
R-HSA-376176	Signaling by ROBO receptors	1/167	190/7349	0.988028486906316	0.997418590609215	0.997418590609215	4690	1	ENSG00000158092	NCK1
R-HSA-68882	Mitotic Anaphase	1/167	191/7349	0.988307749748423	0.997418590609215	0.997418590609215	996	1	ENSG00000004897	CDC27
R-HSA-2555396	Mitotic Metaphase and Anaphase	1/167	192/7349	0.988580536251917	0.997418590609215	0.997418590609215	996	1	ENSG00000004897	CDC27
R-HSA-72766	Translation	2/167	282/7349	0.989471032118304	0.997418590609215	0.997418590609215	124454/8669	2	ENSG00000103356,ENSG00000104131	EARS2,EIF3J
R-HSA-195721	Signaling by WNT	1/167	245/7349	0.996747746291774	0.999846933080255	0.999846933080255	55366	1	ENSG00000205213	LGR4
R-HSA-422475	Axon guidance	3/167	427/7349	0.997296552049206	0.999846933080255	0.999846933080255	3983/4690/4067	3	ENSG00000099204,ENSG00000158092,ENSG00000254087	ABLIM1,NCK1,LYN
R-HSA-68886	M Phase	1/167	342/7349	0.999681480103431	0.999846933080255	0.999846933080255	996	1	ENSG00000004897	CDC27
R-HSA-69278	Cell Cycle, Mitotic	2/167	477/7349	0.999846933080255	0.999846933080255	0.999846933080255	996/4067	2	ENSG00000004897,ENSG00000254087	CDC27,LYN
